CERE
Cerevel Therapeutics Holdings, Inc.
Chief Medical Officer Ramiro Sanchez sold $310K of Cerevel Therapeutics Holdings, Inc.
Sold$310,393
$41.39Price
7,500Shares
−100%Stake
What CERE did after the filing
- The stock from Tue, Dec 19 close, $41.46
- +0.9%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Feb 2 close.
Traded Fri, Dec 15. Filed Tue, Dec 19, 11:15 AM ET, during the session. Returns use the Dec 19 close and the Feb 2 close. Not investment advice.